These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 8208413)

  • 1. Ingested (Oral) Adrenocorticotropic Hormone Inhibits IL-17 in the Central Nervous System in the Mouse Model of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Dittel LJ; Dittel BN; Brod SA
    Immunohorizons; 2022 Jul; 6(7):497-506. PubMed ID: 35868840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oromucosal Administration of Interferon to Humans.
    Beilharz MW; Cummins MJ; Bennett AL; Cummins JM
    Pharmaceuticals (Basel); 2010 Jan; 3(2):323-344. PubMed ID: 27713254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
    Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
    J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS.
    Kalinke U; Prinz M
    Immunol Cell Biol; 2012 May; 90(5):505-9. PubMed ID: 22430251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory functions of type I interferons.
    González-Navajas JM; Lee J; David M; Raz E
    Nat Rev Immunol; 2012 Jan; 12(2):125-35. PubMed ID: 22222875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
    Constantinescu CS; Farooqi N; O'Brien K; Gran B
    Br J Pharmacol; 2011 Oct; 164(4):1079-106. PubMed ID: 21371012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production.
    Masters SL; Mielke LA; Cornish AL; Sutton CE; O'Donnell J; Cengia LH; Roberts AW; Wicks IP; Mills KH; Croker BA
    EMBO Rep; 2010 Aug; 11(8):640-6. PubMed ID: 20596075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.
    Rother KI; Brown RJ; Morales MM; Wright E; Duan Z; Campbell C; Hardin DS; Popovic J; McEvoy RC; Harlan DM; Orlander PR; Brod SA
    Diabetes Care; 2009 Jul; 32(7):1250-5. PubMed ID: 19564474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis.
    Elías-López AL; Marquina B; Gutiérrez-Ortega A; Aguilar D; Gomez-Lim M; Hernández-Pando R
    Clin Exp Immunol; 2008 Oct; 154(1):123-33. PubMed ID: 18727633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses.
    Marinaro M; Boyaka PN; Finkelman FD; Kiyono H; Jackson RJ; Jirillo E; McGhee JR
    J Exp Med; 1997 Feb; 185(3):415-27. PubMed ID: 9053442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.
    Brod SA; Khan M; Kerman RH; Pappolla M
    J Neuroimmunol; 1995 Apr; 58(1):61-9. PubMed ID: 7537281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
    Brod SA; Khan M
    J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse.
    Brown AM; McFarlin DE
    Lab Invest; 1981 Sep; 45(3):278-84. PubMed ID: 6792424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons.
    Brod SA; Burns DK
    Neurology; 1994 Jun; 44(6):1144-8. PubMed ID: 8208413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
    Brod SA; Scott M; Burns DK; Phillips JT
    J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.